MeiraGTx Holdings Is Maintained at Outperform by RBC Capital
MeiraGTx Hldgs Analyst Ratings
RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Cuts Target Price to $9
Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX), Spruce Biosciences (SPRB) and Gossamer Bio (GOSS)
Express News | MeiraGTx Holdings PLC : RBC Cuts Target Price to $9 From $11
Express News | MeiraGTx Holdings PLC - Qtrly Shr Loss $0.76
Express News | MeiraGTx Holdings PLC - Has Agreed to Sell 12.5 Mln Ordinary Shares at $4.00 per Share
Earnings Flash (MGTX) MEIRAGTX Posts Q2 Revenue $282,000
Express News | MeiraGTx Holdings: Financing Led by Sanofi, Which Made a $30 Mln Equity Investment in Co Through Offering
Express News | MeiraGTx Q2 Net Income USD -48.62 Million
Express News | MeiraGTx Q2 Revenue USD 282 Thousand
Express News | MeiraGTx Q2 Income From Operations USD -45.909 Million
Express News | MeiraGTx Q2 EPS USD -0.76
Express News | MeiraGTx Q2 Operating Expenses USD 46.191 Million
Express News | MeiraGTx Holdings: Pricing of Underwritten Offering of 12.5 Mln of Ordinary Shares at $4 per Share
MeiraGTx Announces $50 Million Offering of Ordinary Shares Led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results
Express News | MeiraGTx Holdings: Gross Proceeds From Offering Expected to Be $50 Mln
Express News | MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Lags Revenue Estimates
MeiraGTx Holdings | 10-Q: Q2 2024 Earnings Report